e-learning
resources
Stockholm 2002
Monday 16.09.2002
COPD - Drug therapy 2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease
L. I. Kozlova, Z. R. Aisanov, A. G. Chuchalin (Moscow, Russia)
Source:
Annual Congress 2002 - COPD - Drug therapy 2
Session:
COPD - Drug therapy 2
Session type:
Thematic Poster Session
Number:
1599
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. I. Kozlova, Z. R. Aisanov, A. G. Chuchalin (Moscow, Russia). Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease. Eur Respir J 2002; 20: Suppl. 38, 1599
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Long-term monitoring of respiratory function and influence of selective beta blockers on its decline in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001
Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Alterations in cardiovascular function in COPD and heart failure patients with sarcopenia
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020
COPD phenotypes not linked to increased risk of coronary heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019
Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
OSA as a cause of cardiovascular disease, including heart failure
Source: ERS Conference
Year: 2015
Elevation of cardiac enzymes in COPD patients with respiratory failures
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
Source: International Congress 2019 – More and more COPD
Year: 2019
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010
Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 502s
Year: 2006
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Prevalence and characteristics of congestive heart failure in elderly patients with chronic lung disease
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Respiratory event hospitalizations are reduced in heart failure patients with comorbid chronic obstructive pulmonary disease using a wireless implanted pulmonary artery pressure monitoring system
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012
COPD in heart failure patients
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Should all chronic obstructive pulmonary disease (COPD) patients with cardiac co-morbidities have ambulatory oxygen assessment?
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept